Market Research Report

Global Human Insulin Market Research Report 2021

  • AMR ID : QYR-1179769
  • CAT ID : 7
  • Pages : 94
  • Date : Mar 2021
 

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Insulin Analogs and Biosimilars
Human Insulin Biologics

Segment by Application
Short acting
Intermediate acting
Long acting
Pre-mix Insulin

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed

1 Human Insulin Market Overview
1.1 Product Overview and Scope of Human Insulin
1.2 Human Insulin Segment by Type
1.2.1 Global Human Insulin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Human Insulin Segment by Application
1.3.1 Human Insulin Sales Comparison by Application: (2021-2027)
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Global Human Insulin Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Revenue 2016-2027
1.4.2 Global Human Insulin Sales 2016-2027
1.4.3 Human Insulin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Human Insulin Market Competition by Manufacturers
2.1 Global Human Insulin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Insulin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Insulin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Insulin Manufacturing Sites, Area Served, Product Type
2.5 Human Insulin Market Competitive Situation and Trends
2.5.1 Human Insulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Insulin Players Market Share by Revenue
2.5.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Insulin Retrospective Market Scenario by Region
3.1 Global Human Insulin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Human Insulin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Human Insulin Market Facts & Figures by Country
3.3.1 North America Human Insulin Sales by Country
3.3.2 North America Human Insulin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Insulin Market Facts & Figures by Country
3.4.1 Europe Human Insulin Sales by Country
3.4.2 Europe Human Insulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Insulin Market Facts & Figures by Region
3.5.1 Asia Pacific Human Insulin Sales by Region
3.5.2 Asia Pacific Human Insulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Insulin Market Facts & Figures by Country
3.6.1 Latin America Human Insulin Sales by Country
3.6.2 Latin America Human Insulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Insulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Insulin Sales by Country
3.7.2 Middle East and Africa Human Insulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Insulin Historic Market Analysis by Type
4.1 Global Human Insulin Sales Market Share by Type (2016-2021)
4.2 Global Human Insulin Revenue Market Share by Type (2016-2021)
4.3 Global Human Insulin Price by Type (2016-2021)

5 Global Human Insulin Historic Market Analysis by Application
5.1 Global Human Insulin Sales Market Share by Application (2016-2021)
5.2 Global Human Insulin Revenue Market Share by Application (2016-2021)
5.3 Global Human Insulin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 B. Braun Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Corporation Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Becton, Dickinson Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biocon Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biodel
6.4.1 Biodel Corporation Information
6.4.2 Biodel Description and Business Overview
6.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biodel Product Portfolio
6.4.5 Biodel Recent Developments/Updates
6.5 ELI Lilly
6.5.1 ELI Lilly Corporation Information
6.5.2 ELI Lilly Description and Business Overview
6.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 ELI Lilly Product Portfolio
6.5.5 ELI Lilly Recent Developments/Updates
6.6 Julphar
6.6.1 Julphar Corporation Information
6.6.2 Julphar Description and Business Overview
6.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Julphar Product Portfolio
6.6.5 Julphar Recent Developments/Updates
6.7 NOVO Nordisk
6.6.1 NOVO Nordisk Corporation Information
6.6.2 NOVO Nordisk Description and Business Overview
6.6.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NOVO Nordisk Product Portfolio
6.7.5 NOVO Nordisk Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Wockhardt Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Ypsomed
6.10.1 Ypsomed Corporation Information
6.10.2 Ypsomed Description and Business Overview
6.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ypsomed Product Portfolio
6.10.5 Ypsomed Recent Developments/Updates

7 Human Insulin Manufacturing Cost Analysis
7.1 Human Insulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Insulin
7.4 Human Insulin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Insulin Distributors List
8.3 Human Insulin Customers

9 Human Insulin Market Dynamics
9.1 Human Insulin Industry Trends
9.2 Human Insulin Growth Drivers
9.3 Human Insulin Market Challenges
9.4 Human Insulin Market Restraints

10 Global Market Forecast
10.1 Human Insulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Insulin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Insulin by Type (2022-2027)
10.2 Human Insulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Insulin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human Insulin by Application (2022-2027)
10.3 Human Insulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Insulin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Insulin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

 
Choose License Type

Single User : $2900


Corporate User : $4350


Request Sample Report

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, AMR offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe